168 related articles for article (PubMed ID: 37627868)
1. Exploring New Therapeutic Avenues for Ophthalmic Disorders: Glaucoma-Related Molecular Docking Evaluation and Bibliometric Analysis for Improved Management of Ocular Diseases.
Bodea F; Bungau SG; Negru AP; Radu A; Tarce AG; Tit DM; Bungau AF; Bustea C; Behl T; Radu AF
Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627868
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and eye diseases: a bibliometric study and visualization analysis.
Fu X; Tan H; Huang L; Chen W; Ren X; Chen D
Front Cell Infect Microbiol; 2023; 13():1225859. PubMed ID: 37621873
[TBL] [Abstract][Full Text] [Related]
5. Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020.
Peng C; Kuang L; Zhao J; Ross AE; Wang Z; Ciolino JB
J Control Release; 2022 May; 345():625-645. PubMed ID: 35321827
[TBL] [Abstract][Full Text] [Related]
6. The Application of MicroRNAs in Glaucoma Research: A Bibliometric and Visualized Analysis.
Zhang R; Tao Y; Huang J
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895056
[TBL] [Abstract][Full Text] [Related]
7. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Research Hotspots and Trends of Peripheral Nerve Injuries Based on Web of Science From 2017 to 2021: A Bibliometric Analysis.
Zhang S; Huang M; Zhi J; Wu S; Wang Y; Pei F
Front Neurol; 2022; 13():872261. PubMed ID: 35669875
[TBL] [Abstract][Full Text] [Related]
10. Research focus and thematic trends in magnet hospital research: A bibliometric analysis of the global publications.
Yang W; Liu Y; Zeng T; Wang Y; Hao X; Yang W; Wang H
J Adv Nurs; 2021 Apr; 77(4):2012-2025. PubMed ID: 33450072
[TBL] [Abstract][Full Text] [Related]
11. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
12. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
[TBL] [Abstract][Full Text] [Related]
13. Bibliometric analysis of 100 top cited articles of heart failure-associated diseases in combination with machine learning.
Kuang X; Zhong Z; Liang W; Huang S; Luo R; Luo H; Li Y
Front Cardiovasc Med; 2023; 10():1158509. PubMed ID: 37304963
[TBL] [Abstract][Full Text] [Related]
14. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for ocular melanoma: a bibliometric and visualization analysis from 1991 to 2022.
Tan Y; Lu Y; Chen S; Zou C; Qin B
Front Oncol; 2023; 13():1161759. PubMed ID: 37324010
[TBL] [Abstract][Full Text] [Related]
16. Bibliometric analysis of glaucoma-related literature based on SCIE database: a 10-year literature analysis from 2009 to 2018.
Sun YX; Liu YN; Han Y; Kong FQ; Zhang Y; Labisi SA; Cao K
Int J Ophthalmol; 2020; 13(12):1998-2006. PubMed ID: 33344202
[TBL] [Abstract][Full Text] [Related]
17. Mapping research trends of chronic ocular graft-versus-host disease from 2009 to 2020: a bibliometric analysis.
Xu J; Zhao F; Fang J; Shi M; Pan J; Sun W; Du C
Int Ophthalmol; 2022 Dec; 42(12):3963-3976. PubMed ID: 35799074
[TBL] [Abstract][Full Text] [Related]
18. Bibliometric analysis of tumor necrosis factor in post-stroke neuroinflammation from 2003 to 2021.
Zhao Y; Zhu Q; Bi C; Yuan J; Chen Y; Hu X
Front Immunol; 2022; 13():1040686. PubMed ID: 36389810
[TBL] [Abstract][Full Text] [Related]
19. Visualized Analysis of Global Studies on Cervical Spondylosis Surgery: A Bibliometric Study Based on Web of Science Database and VOSviewer.
Huang T; Zhong W; Lu C; Zhang C; Deng Z; Zhou R; Zhao Z; Luo X
Indian J Orthop; 2022 Jun; 56(6):996-1010. PubMed ID: 35662885
[TBL] [Abstract][Full Text] [Related]
20. Exploring acceptable risk in engineering and operations research and management science by bibliometric analysis.
Zhang Y; Duan Z; Shu P; Deng J
Risk Anal; 2023 Aug; 43(8):1539-1556. PubMed ID: 36307897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
